Vaccination for hepatitis C virus: closing in on an evasive target

Telaprevir Is Effective Given Every 8 or 12 Hours With Ribavirin and Peginterferon Alfa-2a or -2b to Patients With Chronic Hepatitis C

(2010) Patrick Marcellin et al.   GASTROENTEROLOGY

Histologic outcomes in hepatitis C-infected patients with varying degrees of virologic response to interferon-based treatments

(2010) Paul J. Pockros et al.   HEPATOLOGY

Priming of CD4+ and CD8+ T cell responses using a HCV core ISCOMATRIX™ vaccine: A phase I study in healthy volunteers

(2010) Debbie Drane et al.   Human vaccines & immunotherapeutics

Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses

(2010) Michael Houghton   IMMUNOLOGICAL REVIEWS

A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individuals

(2010) Eric J. Gowans et al.   JOURNAL OF HEPATOLOGY

Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial

(2010) Paul Y Kwo et al.   LANCET

Candidate hepatitis C vaccine trials and people who inject drugs: Challenges and opportunities

(2010) Lisa Maher et al.   VACCINE

Immunogenicity and safety of different injection routes and schedules of IC41, a Hepatitis C virus (HCV) peptide vaccine

(2010) Christa Firbas et al.   VACCINE

Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults

(2010) Sharon E. Frey et al.   VACCINE

Phase I clinical study of a peptide vaccination for hepatitis C virus-infected patients with different human leukocyte antigen-class I-A alleles

(2009) Shigeru Yutani et al.   CANCER SCIENCE

DNA vaccine therapy for chronic hepatitis C virus (HCV) infection: immune control of a moving target

(2009) Matti Sällberg et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Thiazolides: a new class of antiviral drugs

(2009) Jean-François Rossignol   Expert Opinion on Drug Metabolism & Toxicology

Spontaneous Control of Primary Hepatitis C Virus Infection and Immunity Against Persistent Reinfection

(2009) William O. Osburn et al.   GASTROENTEROLOGY

EASL Clinical Practice Guidelines: Management of cholestatic liver diseases

(2009)   JOURNAL OF HEPATOLOGY

Cellular Immune Responses during High‐Dose Interferon‐α Induction Therapy for Hepatitis C Virus Infection

(2009) Eleanor Barnes et al.   JOURNAL OF INFECTIOUS DISEASES

Chimpanzees in hepatitis C virus research: 1998–2007

(2009) R.H. Bettauer   JOURNAL OF MEDICAL PRIMATOLOGY

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

(2009) Dongliang Ge et al.   NATURE

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

(2009) David L. Thomas et al.   NATURE

IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy

(2009) Vijayaprakash Suppiah et al.   NATURE GENETICS

Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C

(2009) Yasuhito Tanaka et al.   NATURE GENETICS

Depletion of interfering antibodies in chronic hepatitis C patients and vaccinated chimpanzees reveals broad cross-genotype neutralizing activity

(2009) P. Zhang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C

(2009) Heiner Wedemeyer et al.   VACCINE

Therapeutic Vaccination of Chronic Hepatitis C Nonresponder Patients With the Peptide Vaccine IC41

(2008) Christoph S. Klade et al.   GASTROENTEROLOGY

Improved Virologic Response in Chronic Hepatitis C Genotype 4 Treated With Nitazoxanide, Peginterferon, and Ribavirin

(2008) Jean–François Rossignol et al.   GASTROENTEROLOGY

61 FACTORS INFLUENCING PROGRESSION OF LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS C: RESULTS OF THE 3-YEAR T2S-918-HCV STUDY WITH HCVE1 THERAPEUTIC VACCINATION

(2008) H. Wedemeyer et al.   JOURNAL OF HEPATOLOGY

Prospective analysis of effector and regulatory CD4+ T cells in chronic HCV patients undergoing combination antiviral therapy

(2008) James R. Burton et al.   JOURNAL OF HEPATOLOGY

Towards the non-invasive diagnosis of cirrhosis: The nuts-cirrhosis connection

(2008) Jaime Bosch   JOURNAL OF HEPATOLOGY

Immunogenicity of CIGB-230, a therapeutic DNA vaccine preparation, in HCV-chronically infected individuals in a Phase I clinical trial

(2008) L. Alvarez-Lajonchere et al.   JOURNAL OF VIRAL HEPATITIS

Genetic History of Hepatitis C Virus in East Asia

(2008) O. G. Pybus et al.   JOURNAL OF VIROLOGY

Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection

(2008) Shawn D Blackburn et al.   NATURE IMMUNOLOGY